| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.09B | -1.66B | 912.00M | 5.69B | 3.22B |
| Gross Profit | 2.09B | -1.66B | 1.09B | -5.61B | 2.49B |
| EBITDA | 134.00M | 358.00M | 299.00M | -431.00M | 140.00M |
| Net Income | -99.00M | 80.00M | 129.00M | -376.00M | -35.40M |
Balance Sheet | |||||
| Total Assets | 40.77B | 37.92B | 31.84B | 24.83B | 25.54B |
| Cash, Cash Equivalents and Short-Term Investments | 758.00M | 1.62B | 1.25B | 1.39B | 510.00M |
| Total Debt | 4.37B | 846.00M | 695.00M | 707.90M | 778.20M |
| Total Liabilities | 39.66B | 36.68B | 30.64B | 22.65B | 23.10B |
| Stockholders Equity | 1.11B | 1.25B | 1.21B | 2.18B | 2.44B |
Cash Flow | |||||
| Free Cash Flow | -398.00M | 859.00M | 138.00M | 137.10M | -676.00M |
| Operating Cash Flow | -379.00M | 863.00M | 141.00M | 145.20M | -668.70M |
| Investing Cash Flow | -28.00M | -5.00M | -2.00M | -202.30M | -77.90M |
| Financing Cash Flow | -201.00M | 52.00M | -110.00M | -168.00M | -57.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £642.20M | 7.04 | 11.14% | 7.08% | 15.83% | -93.41% | |
76 Outperform | £1.45B | 6.98 | 15.28% | 11.03% | 8.78% | -38.83% | |
74 Outperform | £2.40B | 8.36 | 8.35% | 3.40% | -28.04% | -102.43% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | £1.38B | 5.39 | 12.70% | 4.74% | -4.98% | 3.02% | |
53 Neutral | £672.06M | -59.40 | -2.93% | 8.03% | -48.03% | -289.17% | |
47 Neutral | £2.27B | -22.73 | -8.84% | 1.22% | -7.30% | -27.69% |